Literature DB >> 1927811

Percutaneous biopsy of skeletal lesions.

S V Kattapuram1, D I Rosenthal.   

Abstract

Percutaneous needle biopsy of lesions affecting the musculoskeletal system should be considered a routine radiologic procedure. Although relatively safe, the procedure requires expertise. An experienced radiologist and the cooperation of a skilled pathologist are essential. Consultation with the orthopedic surgeon is also important, especially when resection of the lesion is contemplated. Recent advances in imaging techniques and the availability of various cutting and trephine needles have made it easier to perform biopsies safely and accurately, even in difficult locations. The procedure obviates surgery in many instances and facilitates appropriate surgical planning in others. This review offers a pragmatic approach to percutaneous needle biopsy of skeletal lesions. It is hoped that more radiologists will be encouraged to undertake these valuable procedures.

Entities:  

Mesh:

Year:  1991        PMID: 1927811     DOI: 10.2214/ajr.157.5.1927811

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  13 in total

1.  CT-guided percutaneous biopsy of thoracic and lumbar spine: A new coaxial technique.

Authors:  Daniel Yaffe; Ghal Greenberg; Joseph Leitner; Reuven Gipstein; Myra Shapiro; Gil N Bachar
Journal:  AJNR Am J Neuroradiol       Date:  2003 Nov-Dec       Impact factor: 3.825

Review 2.  Image-guided percutaneous spinal biopsy.

Authors:  Gajan Rajeswaran; Qaiser Malik; Asif Saifuddin
Journal:  Skeletal Radiol       Date:  2012-06-04       Impact factor: 2.199

3.  CT-guided percutaneous core needle biopsy in deep seated musculoskeletal lesions: a prospective study of 128 cases.

Authors:  A Puri; V U Shingade; M G Agarwal; C Anchan; S Juvekar; S Desai; N A Jambhekar
Journal:  Skeletal Radiol       Date:  2005-12-09       Impact factor: 2.199

4.  Image guided core needle biopsy of musculoskeletal lesions: are nondiagnostic results clinically useful?

Authors:  Manjiri M Didolkar; Megan E Anderson; Mary G Hochman; Julia G Rissmiller; Jeffrey D Goldsmith; Mark G Gebhardt; Jim S Wu
Journal:  Clin Orthop Relat Res       Date:  2013-07-17       Impact factor: 4.176

5.  Bone marrow biopsy: RNA isolation with expression profiling in men with metastatic castration-resistant prostate cancer--factors affecting diagnostic success.

Authors:  Charles E Spritzer; P Diana Afonso; Emily N Vinson; James D Turnbull; Karla K Morris; Adam Foye; John F Madden; Kingshuk Roy Choudhury; Phillip G Febbo; Daniel J George
Journal:  Radiology       Date:  2013-10-28       Impact factor: 11.105

6.  Image-guided musculoskeletal biopsies.

Authors:  Huy B Q Le; Steven T Lee; Peter L Munk
Journal:  Semin Intervent Radiol       Date:  2010-06       Impact factor: 1.513

7.  Image-guided percutaneous bone biopsy with a simulated van sonnenberg removable hub system.

Authors:  Zeynep Maras Ozdemir; Aysegul Sagir Kahraman; Tamer Baysal; Ramazan Kutlu; Mehmet Halil Ozturk; Baki Hekimoglu; Meltem Guvercinci
Journal:  Eurasian J Med       Date:  2014-07-08

8.  Effectiveness of combined use of imprint cytological and histological examination in CT-guided tissue-core biopsy.

Authors:  Takuji Yamagami; Rika Yoshimatsu; Kenji Kajiwara; Masaki Ishikawa; Tomohiro Matsumoto; Hideaki Kakizawa; Naoyuki Toyoda; Terumitsu Hasebe; Kazuo Awai
Journal:  Eur Radiol       Date:  2014-02-14       Impact factor: 5.315

9.  Is Core Needle Biopsy Reliable in Differentiating Between Aggressive Benign and Malignant Radiolucent Bone Tumors?

Authors:  Vishal Hegde; Zachary D C Burke; Howard Y Park; Stephen D Zoller; Daniel Johansen; Benjamin V Kelley; Ben Levine; Kambiz Motamedi; Noah C Federman; Leanne L Seeger; Scott D Nelson; Nicholas M Bernthal
Journal:  Clin Orthop Relat Res       Date:  2018-03       Impact factor: 4.176

Review 10.  Percutaneous bone biopsy, techniques and indications.

Authors:  W Berning; J Freyschmidt; H Ostertag
Journal:  Eur Radiol       Date:  1996       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.